NM_001378969.1:c.1107-96791A>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001378969.1(KCND3):​c.1107-96791A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 152,110 control chromosomes in the GnomAD database, including 12,064 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12064 hom., cov: 32)

Consequence

KCND3
NM_001378969.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.465

Publications

7 publications found
Variant links:
Genes affected
KCND3 (HGNC:6239): (potassium voltage-gated channel subfamily D member 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shal-related subfamily, members of which form voltage-activated A-type potassium ion channels and are prominent in the repolarization phase of the action potential. This member includes two isoforms with different sizes, which are encoded by alternatively spliced transcript variants of this gene. [provided by RefSeq, Jul 2008]
KCND3 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • spinocerebellar ataxia type 19/22
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • Brugada syndrome 9
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378969.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCND3
NM_001378969.1
MANE Select
c.1107-96791A>C
intron
N/ANP_001365898.1
KCND3
NM_004980.5
c.1107-96791A>C
intron
N/ANP_004971.2
KCND3
NM_001378970.1
c.1107-96791A>C
intron
N/ANP_001365899.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCND3
ENST00000302127.5
TSL:5 MANE Select
c.1107-96791A>C
intron
N/AENSP00000306923.4
KCND3
ENST00000315987.6
TSL:1
c.1107-96791A>C
intron
N/AENSP00000319591.2
KCND3
ENST00000369697.5
TSL:1
c.1107-96791A>C
intron
N/AENSP00000358711.1

Frequencies

GnomAD3 genomes
AF:
0.391
AC:
59355
AN:
151992
Hom.:
12061
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.280
Gnomad AMI
AF:
0.569
Gnomad AMR
AF:
0.454
Gnomad ASJ
AF:
0.531
Gnomad EAS
AF:
0.392
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.405
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.424
Gnomad OTH
AF:
0.432
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.390
AC:
59360
AN:
152110
Hom.:
12064
Cov.:
32
AF XY:
0.393
AC XY:
29230
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.280
AC:
11595
AN:
41480
American (AMR)
AF:
0.454
AC:
6945
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.531
AC:
1845
AN:
3472
East Asian (EAS)
AF:
0.392
AC:
2032
AN:
5178
South Asian (SAS)
AF:
0.463
AC:
2235
AN:
4828
European-Finnish (FIN)
AF:
0.405
AC:
4280
AN:
10568
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.424
AC:
28856
AN:
67982
Other (OTH)
AF:
0.429
AC:
907
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1843
3687
5530
7374
9217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
578
1156
1734
2312
2890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.412
Hom.:
15807
Bravo
AF:
0.389
Asia WGS
AF:
0.403
AC:
1403
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.7
DANN
Benign
0.81
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11102353; hg19: chr1-112426519; API